Sexual Toxicity of Cancer Drugs; Guilt and Non-Beneficial Care; Effects of Cannabis

Watchdoq April 18, 2025
(MedPage Today) -- Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. (Lancet Oncology)
U.S. medical centers have appealed to the FDA for compassionate use approval of the adenosine receptor inhibitor...

Read Full Article